A citation-based method for searching scientific literature

A Perry, B W Scheithauer, S L Stafford, C M Lohse, P C Wollan. Cancer 1999
Times Cited: 434







List of co-cited articles
751 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Meningioma grading: an analysis of histologic parameters.
A Perry, S L Stafford, B W Scheithauer, V J Suman, C M Lohse. Am J Surg Pathol 1997
453
37


Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.
Victoria E Clark, E Zeynep Erson-Omay, Akdes Serin, Jun Yin, Justin Cotney, Koray Ozduman, Timuçin Avşar, Jie Li, Phillip B Murray, Octavian Henegariu,[...]. Science 2013
486
32

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
31

The 2007 WHO classification of tumours of the central nervous system.
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues. Acta Neuropathol 2007
25

Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.
Priscilla K Brastianos, Peleg M Horowitz, Sandro Santagata, Robert T Jones, Aaron McKenna, Gad Getz, Keith L Ligon, Emanuele Palescandolo, Paul Van Hummelen, Matthew D Ducar,[...]. Nat Genet 2013
377
25

Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.
Leland Rogers, Igor Barani, Marc Chamberlain, Thomas J Kaley, Michael McDermott, Jeffrey Raizer, David Schiff, Damien C Weber, Patrick Y Wen, Michael A Vogelbaum. J Neurosurg 2015
304
20

TERT Promoter Mutations and Risk of Recurrence in Meningioma.
Felix Sahm, Daniel Schrimpf, Adriana Olar, Christian Koelsche, David Reuss, Juliane Bissel, Annekathrin Kratz, David Capper, Sebastian Schefzyk, Thomas Hielscher,[...]. J Natl Cancer Inst 2015
188
20

Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
L Palma, P Celli, C Franco, L Cervoni, G Cantore. J Neurosurg 1997
207
18

High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.
Stéphane Goutagny, Jean C Nault, Maxime Mallet, Dominique Henin, Jessica Z Rossi, Michel Kalamarides. Brain Pathol 2014
158
18

Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
S-Y Yang, C-K Park, S-H Park, D G Kim, Y S Chung, H-W Jung. J Neurol Neurosurg Psychiatry 2008
182
18

Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.
David E Reuss, Rosario M Piro, David T W Jones, Matthias Simon, Ralf Ketter, Marcel Kool, Albert Becker, Felix Sahm, Stefan Pusch, Jochen Meyer,[...]. Acta Neuropathol 2013
146
18

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Felix Sahm, Daniel Schrimpf, Damian Stichel, David T W Jones, Thomas Hielscher, Sebastian Schefzyk, Konstantin Okonechnikov, Christian Koelsche, David E Reuss, David Capper,[...]. Lancet Oncol 2017
330
18

Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.
M H Ruttledge, J Sarrazin, S Rangaratnam, C M Phelan, E Twist, P Merel, O Delattre, G Thomas, M Nordenskjöld, V P Collins. Nat Genet 1994
443
17

Pathological classification and molecular genetics of meningiomas.
Christian Mawrin, Arie Perry. J Neurooncol 2010
266
17

Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.
Manish K Aghi, Bob S Carter, Garth R Cosgrove, Robert G Ojemann, Sepideh Amin-Hanjani, Robert L Martuza, William T Curry, Fred G Barker. Neurosurgery 2009
302
15

Histological classification and molecular genetics of meningiomas.
Markus J Riemenschneider, Arie Perry, Guido Reifenberger. Lancet Neurol 2006
324
15

Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
J Boström, B Meyer-Puttlitz, M Wolter, B Blaschke, R G Weber, P Lichter, K Ichimura, V P Collins, G Reifenberger. Am J Pathol 2001
179
15

Brain Invasion in Meningiomas: Incidence and Correlations with Clinical Variables and Prognosis.
Dorothee Cäcilia Spille, Katharina Heß, Cristina Sauerland, Nader Sanai, Walter Stummer, Werner Paulus, Benjamin Brokinkel. World Neurosurg 2016
51
29

Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.
Malak Abedalthagafi, Wenya Linda Bi, Ayal A Aizer, Parker H Merrill, Ryan Brewster, Pankaj K Agarwalla, Marc L Listewnik, Dora Dias-Santagata, Aaron R Thorner, Paul Van Hummelen,[...]. Neuro Oncol 2016
148
15

EANO guidelines for the diagnosis and treatment of meningiomas.
Roland Goldbrunner, Giuseppe Minniti, Matthias Preusser, Michael D Jenkinson, Kita Sallabanda, Emmanuel Houdart, Andreas von Deimling, Pantelis Stavrinou, Florence Lefranc, Morten Lund-Johansen,[...]. Lancet Oncol 2016
377
15

Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network.
David Pasquier, Stefan Bijmolt, Theo Veninga, Nicolas Rezvoy, Salvador Villa, Marco Krengli, Damien C Weber, Brigitta G Baumert, Emine Canyilmaz, Deniz Yalman,[...]. Int J Radiat Oncol Biol Phys 2008
155
14

Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria.
Blake E Pearson, James M Markert, Winfield S Fisher, Barton L Guthrie, John B Fiveash, Cheryl A Palmer, Kristen Riley. Neurosurg Focus 2008
126
13

AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry.
Felix Sahm, Juliane Bissel, Christian Koelsche, Leonille Schweizer, David Capper, David Reuss, Katja Böhmer, Ulrike Lass, Tanja Göck, Katrin Kalis,[...]. Acta Neuropathol 2013
68
19

Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.
Victoria E Clark, Akdes Serin Harmancı, Hanwen Bai, Mark W Youngblood, Tong Ihn Lee, Jacob F Baranoski, A Gulhan Ercan-Sencicek, Brian J Abraham, Abraham S Weintraub, Denes Hnisz,[...]. Nat Genet 2016
171
13

Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma.
Ziming Du, Malak Abedalthagafi, Ayal A Aizer, Allison R McHenry, Heather H Sun, Mark-Anthony Bray, Omar Viramontes, Revaz Machaidze, Priscilla K Brastianos, David A Reardon,[...]. Oncotarget 2015
87
13

Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas.
Miriam J Smith, James O'Sullivan, Sanjeev S Bhaskar, Kristen D Hadfield, Gemma Poke, John Caird, Saba Sharif, Diana Eccles, David Fitzpatrick, Daniel Rawluk,[...]. Nat Genet 2013
154
12

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.
Thomas J Kaley, Patrick Wen, David Schiff, Keith Ligon, Sam Haidar, Sasan Karimi, Andrew B Lassman, Craig P Nolan, Lisa M DeAngelis, Igor Gavrilovic,[...]. Neuro Oncol 2015
143
12

Brain invasion in otherwise benign meningiomas does not predict tumor recurrence.
Peter Baumgarten, Florian Gessler, Jens Schittenhelm, Marco Skardelly, Dominique S Tews, Christian Senft, Maika Dunst, Lioba Imoehl, Karl H Plate, Marlies Wagner,[...]. Acta Neuropathol 2016
38
31


Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy.
T W Dziuk, S Woo, E B Butler, J Thornby, R Grossman, W S Dennis, H Lu, L S Carpenter, J K Chiu. J Neurooncol 1998
190
11

Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.
E B Hug, A Devries, A F Thornton, J E Munzenride, F S Pardo, E T Hedley-Whyte, M R Bussiere, R Ojemann. J Neurooncol 2000
214
11

Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review.
Gurvinder Kaur, Eli T Sayegh, Andrew Larson, Orin Bloch, Michelle Madden, Matthew Z Sun, Igor J Barani, C David James, Andrew T Parsa. Neuro Oncol 2014
122
11

Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes.
M Kalamarides, A O Stemmer-Rachamimov, M Niwa-Kawakita, F Chareyre, E Taranchon, Z-Y Han, C Martinelli, E A Lusis, B Hegedus, D H Gutmann,[...]. Oncogene 2011
93
11

Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection.
Sam Q Sun, Albert H Kim, Chunyu Cai, Rory K J Murphy, Todd DeWees, Peter Sylvester, Ralph G Dacey, Robert L Grubb, Keith M Rich, Gregory J Zipfel,[...]. Neurosurgery 2014
74
14

Radiotherapy for atypical or malignant intracranial meningioma.
M F Milosevic, P J Frost, N J Laperriere, C S Wong, W J Simpson. Int J Radiat Oncol Biol Phys 1996
160
11

Epidemiology and etiology of meningioma.
Joseph Wiemels, Margaret Wrensch, Elizabeth B Claus. J Neurooncol 2010
585
11


Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States.
Varun R Kshettry, Quinn T Ostrom, Carol Kruchko, Ossama Al-Mefty, Gene H Barnett, Jill S Barnholtz-Sloan. Neuro Oncol 2015
101
11

WHO grade II and III meningiomas: a study of prognostic factors.
Anne Durand, François Labrousse, Anne Jouvet, Luc Bauchet, Michel Kalamaridès, Philippe Menei, Robert Deruty, Jean Jacques Moreau, Michelle Fèvre-Montange, Jacques Guyotat. J Neurooncol 2009
202
10

Intracranial meningiomas of atypical (WHO grade II) histology.
Leland Rogers, Mark Gilbert, Michael A Vogelbaum. J Neurooncol 2010
105
10

The histopathological spectrum of human meningiomas.
Thomas Backer-Grøndahl, Bjørnar H Moen, Sverre H Torp. Int J Clin Exp Pathol 2012
112
10

A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas.
Arie Perry, Ruma Banerjee, Christine M Lohse, Bette K Kleinschmidt-DeMasters, Bernd W Scheithauer. Brain Pathol 2002
112
10

Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas.
Miriam J Smith, Andrew J Wallace, Chris Bennett, Martin Hasselblatt, Ewelina Elert-Dobkowska, Linton T Evans, William F Hickey, Jack van Hoff, David Bauer, Amy Lee,[...]. J Pathol 2014
77
12

Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review.
Thomas Kaley, Igor Barani, Marc Chamberlain, Michael McDermott, Katherine Panageas, Jeffrey Raizer, Leland Rogers, David Schiff, Michael Vogelbaum, Damien Weber,[...]. Neuro Oncol 2014
125
10

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.
Quinn T Ostrom, Haley Gittleman, Jordonna Fulop, Max Liu, Rachel Blanda, Courtney Kromer, Yingli Wolinsky, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2015
10

Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas.
Ganesh M Shankar, Malak Abedalthagafi, Rachael A Vaubel, Parker H Merrill, Naema Nayyar, Corey M Gill, Ryan Brewster, Wenya Linda Bi, Pankaj K Agarwalla, Aaron R Thorner,[...]. Neuro Oncol 2017
67
14

BAP1 mutations in high-grade meningioma: implications for patient care.
Ganesh M Shankar, Sandro Santagata. Neuro Oncol 2017
80
12

The accuracy of meningioma grading: a 10-year retrospective audit.
J Willis, C Smith, J W Ironside, S Erridge, I R Whittle, D Everington. Neuropathol Appl Neurobiol 2005
141
9

Epidemiology of intracranial meningioma.
Elizabeth B Claus, Melissa L Bondy, Joellen M Schildkraut, Joseph L Wiemels, Margaret Wrensch, Peter M Black. Neurosurgery 2005
343
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.